Deregulation of SIRT1 in CML LSCs promotes the drug resistance and of in CML LSCs by deacetylating many transcription factors, including p53, Ku70, and FOXO151,52. The gene discussed is XRCC6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.